🇺🇸 Weekly Oral Cyclic Antibiotic programme in United States

Weekly Oral Cyclic Antibiotic programme (Weekly Oral Cyclic Antibiotic programme) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Weekly Oral Cyclic Antibiotic programme in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Weekly Oral Cyclic Antibiotic programme approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Weekly Oral Cyclic Antibiotic programme in United States?

University Hospital, Tours is the originator. The local marketing authorisation holder may differ — check the official source linked above.